Advertisement
FDA Alert
FDA Alert
09/11/2023

Anthony Calabro, MA

Anthony Calabro, MA
The FDA approval follows a single-arm, multicenter, open-label trial in 91 patients with uveal melanoma with unresectable hepatic metastases.
09/11/2023